Cabotegravir

Records for this ingredient, by country (identity only).

ATC J05AJ04 · 12 markets · 43 records

Cabotegravir 12 markets · 43 records Forms
Filters
MarketAU 10CA 5GB 4ES 4MX 4TW 4HK 3JP 3SG 2EU 2US 1FR 1
Kind

AU 10 records · 5 shown of 5 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 30 mgtabletVocabriaVOCABRIA cabotegravir (as sodium) 30 mg film-coated tablet, bottle also in CA·GB·ES
    +3Other 3 marketsTWJPUS
     unknown
  • 600 mg per mL / per unit basis not statedinjectionAPRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial unknown

Combination products containing this ingredient

  • 600 mg/3 mLinjection · extended-release CombinationCabotegravir 600 mg/3 mL + Rilpivirine 900 mg/3 mLCabenuva
  • 600 mg per mL / per unit basis not statedinjection CombinationCabotegravir 600 mg + Rilpivirine 900 mgCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown
  • 400 mg per mL / per unit basis not statedinjection CombinationCabotegravir 400 mg + Rilpivirine 600 mgCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Apretude ×12Cabenuva ×2Vocabria ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 5 records · 3 shown of 3 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

  • 30 mgtabletApretudeVocabria also in AU·GB·ES
    +3Other 3 marketsTWJPUS
  • 200 mg per mL / per unit basis not statedliquid · extended-releaseApretude

Combination products containing this ingredient

  • 200 mg per mL / per unit basis not statedliquid · extended-release CombinationCabotegravir 200 mg + Rilpivirine 300 mgCabenuva

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

  • 30 mgtabletApretudeVocabria also in AU·CA·ES
    +3Other 3 marketsTWJPUS
  • 600 mg/3 mLinjection · extended-releaseApretude 600mg/3ml prolonged-release suspension for injection vialsVocabria 600mg/3ml prolonged-release suspension for injection vials also in FR

ES 4 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

Only this ingredient

  • 30 mgtabletApretudeVocabria also in AU·CA·GB
    +3Other 3 marketsTWJPUS
  • 600 mg per mL / per unit basis not statedinjection · extended-releaseApretudeVocabria

MX 4 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Apretude ×12Vocabria ×12

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 4 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

  • 30 mgtabletApretudeVocabria、艾菩盾膜衣錠 30 毫克、莫帕滋膜衣錠30毫克 also in AU·CA·GB
    +3Other 3 marketsESJPUS
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Apretude prolonged-release suspension for injection ×1Vocabria prolonged-release suspension for injection ×5艾菩盾長效注射劑 ×1莫帕滋長效注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Vocabria ×6Vocabria prolonged-release suspension for injection ×10

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 3 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

SG 2 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

EU 2 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Apretude ×6Vocabria ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 600 mg/3 mLinjection · extended-releaseVOCABRIA 600 mg, suspension injectable à libération prolongée also in GB

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.